The report will be delivered in 2-3 business days.

Central Nervous System Drugs Global Market Report 2019

Starting Price : $ 4000.00 | Pages : 300 | Published : January 2019 | SKU CODE : 5285 | Format :


Central Nervous System Drugs Market Characteristics

The central nervous system drugs market consists sales of central nervous system drugs and related services by entities (organizations, sole traders and partnerships) that produce central nervous system drugs to treat brain and spinal cord diseases. This industry includes establishments that produce nervous system drugs, pain reducing analgesics, anti-Parkinson drugs to treat Parkinson’s disease, anticonvulsant anti-epileptics drugs to control epileptic seizures, anaesthetics and other drugs such as muscle relaxants, antiemetics.

Competitive Landscape of the Central Nervous System Drugs Market

Major players in the global Central nervous system drugs market include Biogen Inc, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Pfizer Inc, Novartis AG

Central Nervous System Drugs Market Size

The central nervous system drugs market size is expected to reach $85 billion by 2022, significantly growing at a CAGR of around 5% during the forecast period. The growth in the Central nervous system drugs market is due to steps taken by the US FDA (Food and Drug Administration) and EMA (European Medicines Agency) to offer allotment of special regulatory designations for Central Nervous System disorders which will help in the faster entry of drugs into the market for treatment of serious nervous system related conditions.

However, the market for Central nervous system drugs is expected to face certain restraints from several factors such as increasing government regulations and increasing licence cost.

Central Nervous System Drugs Market Segmentation

The global central nervous system drugs market is further segmented based on type and geography.
By Type - The central nervous system drugs market is segmented into nervous system drugs, analgesics, anti-parkinson drugs, anaesthetics, anti-epileptics, other cns drugs among these segments, the nervous system drugs market accounts for the largest share in the global Central nervous system drugs market.
By Geography - The global central nervous system drugs is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the global central nervous system drugs market.
Trends in the Central Nervous System Drugs Market
Pharmaceutical companies are partnering with technology companies and incorporating wearables in clinical studies and for research and development of CNS disease treatments. These wearable devices make use of sensors to detect early symptoms of Parkinson’s disease such as tremors, slowness and stiffness in patients. Researchers use this data to gain insights about the disease and potential drug reactions, and thus reduce the time for trials by 30% to 50%. For instance, in 2017, Michael J. Fox Foundation for Parkinson’s Research collaborated with specialty drug maker Cynapsus Therapeutics and Intel to integrate wearable technology in a Phase-III clinical trial of APL-130277, an experimental drug for Parkinson’s disease. Biogen, a leading CNS drug maker is using Fitbit, a smart wearable tracker, to better understand multiple sclerosis in patient studies, and the technology is expected to extend in Alzheimer’s disease research. Potential Opportunities in the Central Nervous System Drugs Market With the increase in geriatric population and rise in diseases such as Parkinson’s, Alzheimer’s and other mental disorders that led to strong demand for central nervous system drugs, the scope and potential for the global central nervous system drugs market is expected to significantly rise in the forecast period.

    1. Executive Summary
  • 2. Report Structure
  • 3. Central Nervous System Drugs Market Characteristics
  • 3.1. Market Definition
  • 3.2. Key Segmentations
  • 4. Central Nervous System Drugs Market Product Analysis
  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products
  • 5. Central Nervous System Drugs Market Supply Chain
  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers
  • 6. Central Nervous System Drugs Market Customer Information
  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth
  • 7. Central Nervous System Drugs Market Trends And Strategies
  • 8. Central Nervous System Drugs Market Size And Growth
  • 8.1. Market Size
  • 8.2. Historic Market Growth, Value ($ Billion)
  • 8.2.1. Drivers Of The Market
  • 8.2.2. Restraints On The Market
  • 8.3. Forecast Market Growth, Value ($ Billion)
  • 8.3.1. Drivers Of The Market
  • 8.3.2. Restraints On The Market
  • 9. Central Nervous System Drugs Market Regional Analysis
  • 9.1. Global Central Nervous System Drugs Market, 2018, By Region, Value ($ Billion)
  • 9.2. Global Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • 9.3. Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region
  • 10. Central Nervous System Drugs Market Segmentation
  • 10.1. Global Central Nervous System Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • 10.1.1. Nervous System Drugs
  • 10.1.2. Analgesics
  • 10.1.3. Anti-Parkinson drugs
  • 10.1.4. Anesthetics
  • 10.1.5. Anti-Epileptics
  • 10.1.6. Other CNS drugs
  • 11. Central Nervous System Drugs Market Metrics
  • 11.1. Central Nervous System Drugs Market Size, Percentage Of GDP, 2014 - 2022, Global
  • 11.2. Per Capita Average Central Nervous System Drugs Market Expenditure, 2014 - 2022, Global
  • 12. Asia-Pacific Central Nervous System Drugs Market
  • 12.1. Asia-Pacific Central Nervous System Drugs Market Overview
  • 12.2. Asia-Pacific, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 12.3. Asia-Pacific, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 12.4. Asia-Pacific, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 12.5. Asia-Pacific, Central Nervous System Drugs Market Metrics
  • 12.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Asia-Pacific Countries
  • 12.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Asia-Pacific Countries
  • 12.6. Asia-Pacific Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 12.7. Asia-Pacific Central Nervous System Drugs Market: Country Analysis
  • 12.7.1. China Central Nervous System Drugs Market
  • 12.7.1.1. China Central Nervous System Drugs Market Overview
  • 12.7.1.2. China Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 12.7.1.3. China Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • 12.7.1.4. China Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 12.7.2. Australia Central Nervous System Drugs Market
  • 12.7.2.1. Australia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 12.7.2.2. Australia Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • 12.7.2.3. Australia Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 12.7.3. Hong Kong Central Nervous System Drugs Market
  • 12.7.3.1. Hong Kong Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 12.7.4. India Central Nervous System Drugs Market
  • 12.7.4.1. India Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 12.7.4.2. India Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • 12.7.4.3. India Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 12.7.5. Indonesia Central Nervous System Drugs Market
  • 12.7.5.1. Indonesia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 12.7.6. Japan Central Nervous System Drugs Market
  • 12.7.6.1. Japan Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 12.7.6.2. Japan Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • 12.7.6.3. Japan Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 12.7.7. Malaysia Central Nervous System Drugs Market
  • 12.7.7.1. Malaysia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 12.7.8. New Zealand Central Nervous System Drugs Market
  • 12.7.8.1. New Zealand Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 12.7.9. Philippines Central Nervous System Drugs Market
  • 12.7.9.1. Philippines Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 12.7.10. Singapore Central Nervous System Drugs Market
  • 12.7.10.1. Singapore Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 12.7.11. South Korea Central Nervous System Drugs Market
  • 12.7.11.1. South Korea Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 12.7.12. Thailand Central Nervous System Drugs Market
  • 12.7.12.1. Thailand Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 12.7.13. Vietnam Central Nervous System Drugs Market
  • 12.7.13.1. Vietnam Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 13. Western Europe Central Nervous System Drugs Market
  • 13.1. Western Europe Central Nervous System Drugs Market Overview
  • 13.2. Western Europe, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 13.3. Western Europe, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 13.4. Western Europe, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 13.5. Western Europe, Central Nervous System Drugs Market Metrics
  • 13.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Western Europe Countries
  • 13.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Western Europe Countries
  • 13.6. Western Europe Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 13.7. Western Europe Central Nervous System Drugs Market: Country Analysis
  • 13.7.1. Austria Central Nervous System Drugs Market
  • 13.7.1.1. Austria Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 13.7.2. Belgium Central Nervous System Drugs Market
  • 13.7.2.1. Belgium Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 13.7.3. Denmark Central Nervous System Drugs Market
  • 13.7.3.1. Denmark Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 13.7.4. Finland Central Nervous System Drugs Market
  • 13.7.4.1. Finland Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 13.7.5. France Central Nervous System Drugs Market
  • 13.7.5.1. France Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 13.7.5.2. France Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • 13.7.5.3. France Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 13.7.6. Germany Central Nervous System Drugs Market
  • 13.7.6.1. Germany Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 13.7.6.2. Germany Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • 13.7.6.3. Germany Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 13.7.7. Ireland Central Nervous System Drugs Market
  • 13.7.7.1. Ireland Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 13.7.8. Italy Central Nervous System Drugs Market
  • 13.7.8.1. Italy Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 13.7.8.2. Italy Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • 13.7.8.3. Italy Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 13.7.9. Netherlands Central Nervous System Drugs Market
  • 13.7.9.1. Netherlands Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 13.7.10. Norway Central Nervous System Drugs Market
  • 13.7.10.1. Norway Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 13.7.11. Portugal Central Nervous System Drugs Market
  • 13.7.11.1. Portugal Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 13.7.12. Spain Central Nervous System Drugs Market
  • 13.7.12.1. Spain Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 13.7.12.2. Spain Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • 13.7.12.3. Spain Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 13.7.13. Sweden Central Nervous System Drugs Market
  • 13.7.13.1. Sweden Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 13.7.14. Switzerland Central Nervous System Drugs Market
  • 13.7.14.1. Switzerland Central Nervous System Drugs Market2013 - 2022, Value ($ Billion)
  • 13.7.15. UK Central Nervous System Drugs Market
  • 13.7.15.1. UK Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 13.7.15.2. UK Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • 13.7.15.3. UK Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 14. Eastern Europe Central Nervous System Drugs Market
  • 14.1. Eastern Europe Central Nervous System Drugs Market Overview
  • 14.2. Eastern Europe, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 14.3. Eastern Europe, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 14.4. Eastern Europe, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 14.5. Eastern Europe, Central Nervous System Drugs Market Metrics
  • 14.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Eastern Europe Countries
  • 14.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Eastern Europe Countries
  • 14.6. Eastern Europe Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 14.7. Eastern Europe Central Nervous System Drugs Market: Country Analysis
  • 14.7.1. Czech Republic Central Nervous System Drugs Market,  
  • 14.7.1.1. Czech Republic Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 14.7.2. Poland Central Nervous System Drugs Market
  • 14.7.2.1. Poland Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 14.7.3. Romania Central Nervous System Drugs Market
  • 14.7.3.1. Romania Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 14.7.4. Russia Central Nervous System Drugs Market
  • 14.7.4.1. Russia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 14.7.4.2. Russia Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • 14.7.4.3. Russia Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 15. North America Central Nervous System Drugs Market
  • 15.1. North America Central Nervous System Drugs Market Overview
  • 15.2. North America, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 15.3. North America, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 15.4. North America, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 15.5. North America, Central Nervous System Drugs Market Metrics
  • 15.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, North America Countries
  • 15.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, North America Countries
  • 15.6. North America Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 15.7. North America Central Nervous System Drugs Market: Country Analysis
  • 15.7.1. Canada Central Nervous System Drugs Market
  • 15.7.1.1. Canada Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 15.7.2. Mexico Central Nervous System Drugs Market
  • 15.7.2.1. Mexico Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 15.7.3. USA Central Nervous System Drugs Market
  • 15.7.3.1. USA Central Nervous System Drugs Market Overview
  • 15.7.3.2. USA Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 15.7.3.3. USA Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • 15.7.3.4. USA Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 16. South America Central Nervous System Drugs Market
  • 16.1. South America Central Nervous System Drugs Market Overview
  • 16.2. South America, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 16.3. South America, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 16.4. South America, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 16.5. South America, Central Nervous System Drugs Market Metrics
  • 16.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, South America Countries
  • 16.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, South America Countries
  • 16.6. South America Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 16.7. South America Central Nervous System Drugs Market: Country Analysis
  • 16.7.1. Argentina Central Nervous System Drugs Market
  • 16.7.1.1. Argentina Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 16.7.2. Brazil Central Nervous System Drugs Market
  • 16.7.2.1. Brazil Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 16.7.2.2. Brazil Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • 16.7.2.3. Brazil Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 16.7.3. Chile Central Nervous System Drugs Market
  • 16.7.3.1. Chile Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 16.7.4. Colombia Central Nervous System Drugs Market
  • 16.7.4.1. Colombia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 16.7.5. Peru Central Nervous System Drugs Market
  • 16.7.5.1. Peru Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 16.7.6. Venezuela Central Nervous System Drugs Market
  • 16.7.6.1. Venezuela Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 17. Middle East Central Nervous System Drugs Market
  • 17.1. Middle East Central Nervous System Drugs Market Overview
  • 17.2. Middle East, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 17.3. Middle East, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 17.4. Middle East, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 17.5. Middle East, Central Nervous System Drugs Market Metrics
  • 17.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Middle East Countries
  • 17.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Middle East Countries
  • 17.6. Middle East Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 17.7. Middle East Central Nervous System Drugs Market: Country Analysis
  • 17.7.1. Saudi Arabia Central Nervous System Drugs Market
  • 17.7.1.1. Saudi Arabia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 17.7.2. Israel Central Nervous System Drugs Market
  • 17.7.2.1. Israel Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 17.7.3. Turkey Central Nervous System Drugs Market
  • 17.7.3.1. Turkey Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 17.7.4. UAE Central Nervous System Drugs Market
  • 17.7.4.1. UAE Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 18. Africa Central Nervous System Drugs Market
  • 18.1. Africa Central Nervous System Drugs Market Overview
  • 18.2. Africa, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 18.3. Africa, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 18.4. Africa, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 18.5. Africa, Central Nervous System Drugs Market Metrics
  • 18.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Africa Countries
  • 18.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Africa Countries
  • 18.6. Africa Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 18.7. Africa Central Nervous System Drugs Market: Country Analysis
  • 18.7.1. Egypt Central Nervous System Drugs Market
  • 18.7.1.1. Egypt Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 18.7.2. Nigeria Central Nervous System Drugs Market
  • 18.7.2.1. Nigeria Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 18.7.3. South Africa Central Nervous System Drugs Market
  • 18.7.3.1. South Africa Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • 19. Central Nervous System Drugs Market Competitive Landscape
  • 19.1. Competitive Market Overview
  • 19.2. Market Shares
  • 19.3. Company Profiles
  • 19.3.1. Biogen Inc
  • 19.3.1.1. Company Overview
  • 19.3.1.2. Company Central Nervous System Drugs Market Structure And Strategy
  • 19.3.1.3. Company Central Nervous System Drugs Market Products And Services
  • 19.3.1.4. Financial Performance
  • 19.3.2. F. Hoffmann-La Roche Ltd
  • 19.3.2.1. Company Overview
  • 19.3.2.2. Company Central Nervous System Drugs Market Structure And Strategy
  • 19.3.2.3. Company Central Nervous System Drugs Market Products And Services
  • 19.3.2.4. Financial Performance
  • 19.3.3. Johnson & Johnson
  • 19.3.3.1. Company Overview
  • 19.3.3.2. Company Central Nervous System Drugs Market Structure And Strategy
  • 19.3.3.3. Company Central Nervous System Drugs Market Products And Services
  • 19.3.3.4. Financial Performance
  • 19.3.4. Pfizer Inc
  • 19.3.4.1. Company Overview
  • 19.3.4.2. Company Central Nervous System Drugs Market Structure And Strategy
  • 19.3.4.3. Company Central Nervous System Drugs Market Products And Services
  • 19.3.4.4. Financial Performance
  • 19.3.5. Novartis AG
  • 19.3.5.1. Company Overview
  • 19.3.5.2. Company Central Nervous System Drugs Market Structure And Strategy
  • 19.3.5.3. Company Central Nervous System Drugs Market Products And Services
  • 19.3.5.4. Financial Performance
  • 20. Key Mergers And Acquisitions In The Central Nervous System Drugs Market
  • 21. Market Background: Pharmaceutical Drugs Market
  • 21.1. Pharmaceutical Drugs Market Characteristics
  • 21.2. Pharmaceutical Drugs Market Historic and Forecast, 2014 - 2022 Growth, by segment, Value ($ Billion), Global
  • 21.3. Global Pharmaceutical Drugs Market, 2018, By Region, Value ($ Billion)
  • 21.4. Global Pharmaceutical Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • 21.5. Global Pharmaceutical Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 22. Recommendations
  • 22.1. Global Central Nervous System Drugs Market In 2022- Growth Countries
  • 22.2. Global Central Nervous System Drugs Market In 2022- Growth Segments
  • 22.3. Global Central Nervous System Drugs Market In 2022- Growth Strategies
  • 23. Appendix
  • 23.1. NAICS Definitions Of Industry Covered In This Report
  • 23.2. Abbreviations
  • 23.3. Currencies
  • 23.4. Research Inquiries
  • 23.5. The Business Research Company
  • 24. Copyright And Disclaimer

List Of Tables

    Table 1: Historic Market Growth, Value ($ Billion)
  • Table 2: Forecast Market Growth, Value ($ Billion)
  • Table 3: Global Central Nervous System Drugs Market, 2018, By Region, Value ($ Billion)
  • Table 4: Global Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • Table 5: Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region
  • Table 6: Global Central Nervous System Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Table 7: Central Nervous System Drugs Market Size, Percentage Of GDP, 2014 - 2022, Global
  • Table 8: Per Capita Average Central Nervous System Drugs Market Expenditure, 2014 - 2022, Global
  • Table 9: Asia-Pacific, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • Table 10: Asia-Pacific, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Table 11: Asia-Pacific, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Table 12: Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Asia-Pacific Countries
  • Table 13: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Asia-Pacific Countries
  • Table 14: Asia-Pacific Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 15: China Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 16: China Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Table 17: China Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 18: Australia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 19: Australia Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Table 20: Australia Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 21: Hong Kong Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 22: India Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 23: India Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Table 24: India Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 25: Indonesia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 26: Japan Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 27: Japan Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Table 28: Japan Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 29: Malaysia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 30: New Zealand Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 31: Philippines Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 32: Singapore Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 33: South Korea Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 34: Thailand Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 35: Vietnam Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 36: Western Europe, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • Table 37: Western Europe, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Table 38: Western Europe, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Table 39: Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Western Europe Countries
  • Table 40: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Western Europe Countries
  • Table 41: Western Europe Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 42: Austria Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 43: Belgium Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 44: Denmark Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 45: Finland Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 46: France Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 47: France Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Table 48: France Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 49: Germany Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 50: Germany Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Table 51: Germany Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 52: Ireland Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 53: Italy Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 54: Italy Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Table 55: Italy Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 56: Netherlands Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 57: Norway Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 58: Portugal Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 59: Spain Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 60: Spain Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Table 61: Spain Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 62: Sweden Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 63: Switzerland Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 64: UK Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 65: UK Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Table 66: UK Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 67: Eastern Europe, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • Table 68: Eastern Europe, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Table 69: Eastern Europe, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Table 70: Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Eastern Europe Countries
  • Table 71: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Eastern Europe Countries
  • Table 72: Eastern Europe Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 73: Czech Republic Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 74: Poland Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 75: Romania Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 76: Russia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 77: Russia Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Table 78: Russia Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 79: North America, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • Table 80: North America, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Table 81: North America, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Table 82: Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, North America Countries
  • Table 83: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, North America Countries
  • Table 84: North America Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 85: Canada Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 86: Mexico Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 87: USA Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 88: USA Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Table 89: USA Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 90: South America, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • Table 91: South America, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Table 92: South America, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Table 93: Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, South America Countries
  • Table 94: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, South America Countries
  • Table 95: South America Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 96: South America Nervous System Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Table 97: South America Analgesics Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Table 98: South America Anti-Parkinson drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Table 99: South America Anesthetics Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Table 100: South America Anti-Epileptics Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Table 101: South America Other CNS drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Table 102: Argentina Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 103: Brazil Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 104: Brazil Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Table 105: Brazil Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 106: Chile Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 107: Colombia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 108: Peru Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 109: Venezuela Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 110: Middle East, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • Table 111: Middle East, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Table 112: Middle East, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Table 113: Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Middle East Countries
  • Table 114: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Middle East Countries
  • Table 115: Middle East Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 116: Saudi Arabia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 117: Israel Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 118: Turkey Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 119: UAE Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 120: Africa, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • Table 121: Africa, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Table 122: Africa, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Table 123: Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Africa Countries
  • Table 124: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Africa Countries
  • Table 125: Africa Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 126: Egypt Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 127: Nigeria Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 128: South Africa Central Nervous System Drugs Market2014 - 2022, Value ($ Billion)
  • Table 129: Biogen Inc Financial Performance
  • Table 130: F. Hoffmann-La Roche Ltd Financial Performance
  • Table 131: Johnson & Johnson Financial Performance
  • Table 132: Pfizer Inc Financial Performance
  • Table 133: Novartis AG Financial Performance
  • Table 134: Pharmaceutical Drugs Market Historic and Forecast, 2014 - 2022, Growth, By Segment, Value ($ Billion), Global
  • Table 135: Global Pharmaceutical Drugs Market, 2018, By Region, Value ($ Billion)
  • Table 136: Global Pharmaceutical Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • Table 137: Global Pharmaceutical Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 138: Global Central Nervous System Drugs Market In 2022- Growth Countries
  • Table 139: Global Central Nervous System Drugs Market In 2022- Growth Segments
  • Table 140: Global Central Nervous System Drugs Market In 2022- Growth Strategies

List Of Figures

    Figure 1: Historic Market Growth, Value ($ Billion)
  • Figure 2: Forecast Market Growth, Value ($ Billion)
  • Figure 3: Global Central Nervous System Drugs Market, 2018, By Region, Value ($ Billion)
  • Figure 4: Global Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • Figure 5: Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region
  • Figure 6: Global Central Nervous System Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Figure 7: Central Nervous System Drugs Market Size, Percentage Of GDP, 2014 - 2022, Global
  • Figure 8: Per Capita Average Central Nervous System Drugs Market Expenditure, 2014 - 2022, Global
  • Figure 9: Asia-Pacific, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 10: Asia-Pacific, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 11: Asia-Pacific, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 12: Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Asia-Pacific Countries
  • Figure 13: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Asia-Pacific Countries
  • Figure 14: Asia-Pacific Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 15: China Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 16: China Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 17: China Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 18: Australia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 19: Australia Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 20: Australia Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 21: Hong Kong Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 22: India Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 23: India Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 24: India Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 25: Indonesia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 26: Japan Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 27: Japan Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 28: Japan Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 29: Malaysia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 30: New Zealand Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 31: Philippines Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 32: Singapore Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 33: South Korea Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 34: Thailand Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 35: Vietnam Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 36: Western Europe, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 37: Western Europe, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 38: Western Europe, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 39: Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Western Europe Countries
  • Figure 40: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Western Europe Countries
  • Figure 41: Western Europe Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 42: Austria Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 43: Belgium Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 44: Denmark Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 45: Finland Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 46: France Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 47: France Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 48: France Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 49: Germany Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 50: Germany Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 51: Germany Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 52: Ireland Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 53: Italy Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 54: Italy Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 55: Italy Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 56: Netherlands Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 57: Norway Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 58: Portugal Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 59: Spain Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 60: Spain Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 61: Spain Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 62: Sweden Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 63: Switzerland Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 64: UK Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 65: UK Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 66: UK Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 67: Eastern Europe, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 68: Eastern Europe, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 69: Eastern Europe, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 70: Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Eastern Europe Countries
  • Figure 71: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Eastern Europe Countries
  • Figure 72: Eastern Europe Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 73: Czech Republic Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 74: Poland Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 75: Romania Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 76: Russia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 77: Russia Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 78: Russia Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 79: North America, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 80: North America, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 81: North America, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 82: Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, North America Countries
  • Figure 83: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, North America Countries
  • Figure 84: North America Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 85: Canada Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 86: Mexico Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 87: USA Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 88: USA Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 89: USA Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 90: South America, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 91: South America, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 92: South America, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 93: Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, South America Countries
  • Figure 94: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, South America Countries
  • Figure 95: South America Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 96: South America Nervous System Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Figure 97: South America Analgesics Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Figure 98: South America Anti-Parkinson drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Figure 99: South America Anesthetics Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Figure 100: South America Anti-Epileptics Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Figure 101: South America Other CNS drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Figure 102: Argentina Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 103: Brazil Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 104: Brazil Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 105: Brazil Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 106: Chile Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 107: Colombia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 108: Peru Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 109: Venezuela Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 110: Middle East, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 111: Middle East, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 112: Middle East, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 113: Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Middle East Countries
  • Figure 114: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Middle East Countries
  • Figure 115: Middle East Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 116: Saudi Arabia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 117: Israel Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 118: Turkey Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 119: UAE Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 120: Africa, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 121: Africa, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 122: Africa, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 123: Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Africa Countries
  • Figure 124: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Africa Countries
  • Figure 125: Africa Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 126: Egypt Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 127: Nigeria Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 128: South Africa Central Nervous System Drugs Market2014 - 2022, Value ($ Billion)
  • Figure 129: Biogen Inc Financial Performance
  • Figure 130: F. Hoffmann-La Roche Ltd Financial Performance
  • Figure 131: Johnson & Johnson Financial Performance
  • Figure 132: Pfizer Inc Financial Performance
  • Figure 133: Novartis AG Financial Performance
  • Figure 134: Pharmaceutical Drugs Market Historic and Forecast, 2014 - 2022, Growth, By Segment, Value ($ Billion), Global
  • Figure 135: Global Pharmaceutical Drugs Market, 2018, By Region, Value ($ Billion)
  • Figure 136: Global Pharmaceutical Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • Figure 137: Global Pharmaceutical Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 138: Global Central Nervous System Drugs Market In 2022- Growth Countries
  • Figure 139: Global Central Nervous System Drugs Market In 2022- Growth Segments
  • Figure 140: Global Central Nervous System Drugs Market In 2022- Growth Strategies
Global Biologics Market, Opportunities And Strategies Market | Characteristics, Forecast Size, Trends
Biologics Market Global Opportunities And Strategies To 2021
View Report
Pharmaceutical Drugs Market Global Opportunities And Strategies To 2021
View Report
Cardiovascular Drugs Global Market Report 2019
View Report
Dermatology Drugs Global Market Report 2019
View Report
Gastrointestinal Drugs Global Market Report 2019
View Report
Hematology Drugs Global Market Report 2019
View Report
Anti-Infective Drugs Global Market Report 2019
View Report
Metabolic Disorders Drugs Global Market Report 2019
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)